Aurobindo Pharma Ltd.'s third-quarter profit decreased, missing analysts' estimates. The Hyderabad-based bulk and generic drug maker's net profit fell 9.7% year-on-year to Rs 846 crore in the quarter ...

Bonus Mar 07, 2000 Apr 01, 2000 Feb 22, 2000 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Oct 26, 1998 Nov 19, 1998 Oct 08, 1998 Bonus Ratio: 1 share(s) for every 1 shares held Aurobindo ...

Lexapro (escitalopram) and Zoloft (sertraline) are two prescription medications classified as selective serotonin reuptake inhibitors (SSRIs) used to treat mood disorders, like depression and anxiety.

Brokerage firm Investec has initiated a FAST (a high conviction short-term analyst idea) on drug manufacturer Aurobindo Pharma Ltd. with a price target of ₹1,930. Investec's price target implies a ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Generic drugmaker Aurobindo Pharma has received order under the Central Goods and Services Tax Act, 2017, asking it to pay GST, interest and a penalty of more than ₹155 crore. Additional ...

Revenue 29,001.87 24,855.38 23,455.49 24,774.62 ...

HYDERABAD: Degrowth in its US formulations business dragged down Aurobindo Pharma’s consolidated net profits for the third quarter ended December 31, 2024, by 10% to Rs 846 crore from Rs 940 ...

Aurobindo Pharma posted a mixed financial performance for the December quarter, with strong revenue growth but a decline in net profit and margins. The company’s earnings failed to meet analysts’ ...

The financier had been prescribed sertraline, citalopram - both selective serotonin reuptake inhibitors (SSRIs) - and zopiclone, a sleeping tablet, before his death. Following an inquest into his ...

These medications include duloxetine, escitalopram, buspirone, venlafaxine, and sertraline. Several medications may help treat anxiety in older adults. They typically include antidepressants ...